MedPath

Efficacy and Safety of Mate Extracts on Decrement of Body and Abdominal Fat in Obese Subjects

Phase 2
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Mate extract
Dietary Supplement: Placebo
Registration Number
NCT01778257
Lead Sponsor
Chonbuk National University Hospital
Brief Summary

Obesity is a major health issue worldwide; there is a constant raise in obesity related death each year.

Detailed Description

The primary aim of the study was to investigate the effect of Mate extracts in Korean subjects on body fat and abdominal fat, double blind, placebo-controlled clinical trial.

Thirty obesity subjects with BMI ≥ 25 kg/㎡ and waist-hip ratio (WHR)≥ 0.90 for men and ≥ 0.85 for women were for 12 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Volunteers aged 19 to 65 years
  • 25 kg/m2 ≤ BMI ≥35 kg/m2
  • Ability to give informed consent
Exclusion Criteria
  • Significant variation in weight (more 10%) in the past 3 month
  • Cardiovascular disease, neurologic or psychiatric disease, renal, pulmonary and hepatic abnormalities
  • History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease (Crohn's disease) or gastrointestinal surgery (a caesum or enterocele surgery are included)
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the sutdy
  • Allergic or hypersensitive to any of the ingredients in the test products
  • Pregnancy or breast feeding
  • Used antipsychosis drugs therapy within past 2 months
  • History of alcohol or substance abuse (21 units/week over)
  • Participation in any other clinical trials within past 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mate extracts groupMate extractMate extract(3150 mg/day)for 12 weeks
Placebo groupPlaceboPlacebo (3150 mg/day) for 12 weeks
Primary Outcome Measures
NameTimeMethod
Changes in body and abdominal fatbody fat: baseline, 6 weeks and 12 weeks, abdominal fat of CT: baseline and 12 weeks
Secondary Outcome Measures
NameTimeMethod
Changes in anthropometric parameters(weight, BMI, waist and hip circumference)baseline, 6 weeks and 12 weeks
Changes in blood lipid profile(total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, free fatty acid)baseline, 6 weeks and 12 weeks
© Copyright 2025. All Rights Reserved by MedPath